44 results
PRE 14A
RVNC
Revance Therapeutics Inc
12 Mar 21
Preliminary proxy
4:13pm
or death.
We believe that our continuing directors as a group have an appropriate mix of qualifications, attributes, skills and experience … . The following table and graphics provide summary information about the qualifications, attributes, skills and experience of our continuing directors.
Table
8-K
EX-99.2
v21y1eguxjl9teje9
22 Feb 21
Revance Reports Fourth Quarter and Full Year 2020 Financial Results
4:06pm
8-K
EX-99.1
2djp ndkciy73tvil
22 Feb 21
Revance Reports Fourth Quarter and Full Year 2020 Financial Results
4:06pm
8-K
EX-10.2
u8civl0
28 Feb 24
Provides Corporate Update
4:07pm
8-K
EX-99.2
b92u55r0n
10 Feb 20
Revance Announces Proposed Private Offering of
4:01pm